Kanabo Group Plc is a healthcare-focused company specializing in the development and distribution of cannabis-derived products. With an emphasis on improving the health and wellness sector, Kanabo develops proprietary formulas and technologies aimed at producing medical-grade cannabis products. The company’s offerings include vaporization devices and formulations tailored for precise dosing of cannabinoid concentrates, catering primarily to the medical markets. Kanabo’s engagement extends across various industries, including pharma and biotech, where it collaborates to integrate cannabinoid treatments into traditional healthcare solutions. Headquartered in the United Kingdom, Kanabo Group stands out for its commitment to improving therapeutic outcomes through innovative delivery methods, positioning itself as a pivotal player in the expanding field of medical cannabis. It plays an essential role in advancing the accessibility and effectiveness of cannabis-based therapies, impacting patient care and regulatory landscapes globally.